title: [No increased risk of cancer under pimecrolimus].
authors.affiliation: Département de dermatologie et allergologie, bâtiment des spécialités médicales, 6, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France. Electronic address: jl.schmutz@chu-nancy.fr.
authors.forename: J-L
authors.initials: JL
authors.lastname: Schmutz
mesh_terms: D002648:Child; D002675:Child, Preschool; D003876:Dermatitis, Atopic / Q000188:drug therapy; D003879:Dermatologic Agents / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007223:Infant; D008223:Lymphoma / Q000139:chemically induced; D012878:Skin Neoplasms / Q000139:chemically induced*; D013472:Sunlight / Q000009:adverse effects; D016559:Tacrolimus / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; C117268:pimecrolimus; D016559:Tacrolimus